Courtney Havens
Director of Biology SK Life Sciences
Courtney Havens is Director of Biology at SK Life Sciences (formetly Proteovant Therapeutics), bringing extensive experience from prior roles in drug discovery biology at Treeline Biosciences and senior scientific positions at Pfizer. She holds a PhD from the University of California, San Diego School of Medicine.
Seminars
This workshop will help attendees master two critical enabling technologies, proteomics and AI. Discussions will revolve around how to design and apply proteomics workflows for selectivity profiling and mechanistic clarity, and how to use AI-driven analytics to interpret complex datasets and accelerate degrader design and modeling. By the end of the session, attendees will have practical strategies to improve reliable data generation and analysis and how to use this to inform critical drug design decisions.
Key Takeaways:
- Integrating high-throughput discovery platforms into your workflows to accelerate the discovery and development of molecular glues
- Beyond screening: Accelerating TPD and induced proximity discovery with agentic AI and large language models
- Exploring case studies on how advanced biotechs combine the latest platform technology and AI tools to reduce experimental burden, improve translational predictability, and enable scalable discovery
